Merck and Moderna Announce Exercise of Option by Merck for Joint Development and ...
ACCESSWIRE· 5 個月前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Scanning New Horizons for Bold Solutions
ACCESSWIRE· 5 個月前NORTHAMPTON, MA / ACCESSWIRE / October 26, 2022 / Baker Hughes Meet the team working to bring ...
Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved ...
ACCESSWIRE· 5 個月前Teva Pharmaceuticals, the National Association of Free and Charitable Clinics (NAFC) and Direct ...
Lung Cancer Is Personal: Interview With Lee James
ACCESSWIRE· 5 個月前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Bristol Myers Squibb Company non-small cell ...
Why Clinical Trial Diversity Is So Important - and What the Healthcare Sector Can Do
ACCESSWIRE· 5 個月前Physicians prescribe medication and design treatment and therapy plans for their patients based ...
The Robert A. Winn Diversity in Clinical Trials Award Program Announces the Second Group of ...
ACCESSWIRE· 5 個月前The Bristol Myers Squibb Foundation (BMSF), together with Virginia Commonwealth University ...
RNA Sequencing Critical to Identifying Key Fusions for Oncology Patients
ACCESSWIRE· 5 個月前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Illumina: At the Phoenix Convention Center in ...
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 3 個月前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
Rarebase Is on the Hunt for Therapeutic Opportunities
ACCESSWIRE· 5 個月前San Francisco Bay Area residents Jainu and Shruti Jogani had their newborn daughter, Reyna, at ...
Working Trees: How a Startup Helps Farmers Get Paid for Carbon Stored in Their Trees
ACCESSWIRE· 5 個月前Now that the Cisco Global Problem Solver Challenge 2022 winners have been officially announced, ...
